 | Up a level |
Number of items: 1.
Wehling, Cyrill, Amon, Oliver, Bommer, Martin, Hoppe, Bernd, Kentouche, Karim, Schalk, Gesa, Weimer, Rolf, Wiesener, Michael, Tonshoff, Burkhard and Kirschfink, Michael (2014). Complement activation biomarkers under Eculizumab treatment in patients with atypical hemolytic-uremic syndrome (aHUS), membrano-proliferative glomerulonephritis (MPGN) and antibody-mediated renal graft rejection (AMR). Mol. Immunol., 61 (2). S. 259 - 260. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890